B

BioMark Diagnostics Inc
SWB:20B

Watchlist Manager
BioMark Diagnostics Inc
SWB:20B
Watchlist
Price: 0.167 EUR -5.65% Market Closed
Market Cap: 15.2m EUR

EV/EBIT
Enterprise Value to EBIT

-14.1
Current
-12.5
Median
12.4
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-14.1
=
Enterprise Value
27.6m CAD
/
EBIT
-2m CAD
EBIT Growth EV/EBIT to Growth
CA
B
BioMark Diagnostics Inc
SWB:20B
Average EV/EBIT: 40 265.8
Negative Multiple: -14.1
N/A N/A
UK
E
Eight Capital Partners PLC
F:ECS
Not Available N/A N/A
CA
Australian Goldfields Ltd
OTC:GRXXF
Negative Multiple: -7 705 229.1 N/A N/A
US
G
GE Vernova LLC
NYSE:GEV
Not Available
78%
N/A
IN
S
SAB Industries Ltd
BSE:539112
158 241.5
N/A N/A
US
C
China Industrial Group Inc
OTC:CIND
2 699.3
N/A N/A
NL
N
Nepi Rockcastle NV
JSE:NRP
Not Available
12%
N/A
US
C
CoreWeave Inc
NASDAQ:CRWV
Not Available
136%
N/A
US
Coupang Inc
F:788
80.9
83%
1
ID
Amman Mineral Internasional Tbk PT
IDX:AMMN
41.4
N/A N/A
CH
G
Galderma Group AG
SIX:GALD
Not Available
35%
N/A

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A